UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1)*
AMERICAN DENTAL TECHNOLOGIES, INC.
(Name of Issuer)
Common Stock, $.O4 par value
(Title of Class of Securities)
025352-10-5
(CUSIP Number)
Mark A. Metz
Dykema Gossett PLLC, 400 Renaissance Center, Detroit, Michigan 48243
(Name, Address and Telephone Number of Person Authorized to
Receive Notices and Communications)
July 31, 1999
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to
report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1(b)(3) or (4), check the following
box [ ].
Note: Six copies of this statement, including all exhibits, should be filed
with the Commission. See Rule 13d-1(a) for other parties to whom copies are
to be sent.
*The remainder of this cover page shall be filled out for a reporting
person's initial filing on this form with respect to the subject class of
securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be
deemed to be "filed" for the purpose of Section 18 of the Securities
Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that
section of the Act but shall be subject to all other provisions of the Act
(however, see the Notes).
SCHEDULE 13D
CUSIP No. 025352-10-5
1 Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Ben J. Gallant
2 Check The Appropriate Box If A Member Of A Group* (a) [ ]
(b) [ ]
3 SEC Use Only
4 Source of Funds*
OO
5 Check Box If Disclosure Of Legal Proceedings Is [ ]
Required Pursuant To Items 2(d) or 2(E)
6 Citizenship Or Place of Organization
United States
7 Sole Voting Power
956,864
Number Of
Shares 8 Shared Voting Power
Beneficially 0
Owned By
Each 9 Sole Dispositive Power
Reporting 956,864
Person
With 10 Shared Dispositive Power
0
11 Aggregate Amount of Beneficially Owned By Each Reporting Person
956,864
12 Check Box If The Aggregate Amount In Row (11) Excludes [ ]
Certain Shares*
13 Percent Of Class Represented By Amount In Row (11)
12.8%
14 Type Of Reporting Person*
IN
This is the first amendment to a Statement on Schedule 13D
originally filed with the Securities and Exchange Commission on or about
August 9, 1996 (the "Original Statement") with respect to the common stock,
$.04 par value (the "Common Stock"), of American Dental Technologies, Inc.
("ADT") by Ben J. Gallant. Items 1, 2 and 5 of the Original Statement are
amended as set forth below:
ITEM 1. SECURITY AND ISSUER.
Item 1 is amended and restated in its entirety as follows:
This statement relates to the $.04 par value common stock ("Stock")
of American Dental Technologies, Inc. ("ADT"). The principal executive
office of ADT is located at 5555 Bear Lane, Corpus Christi, Texas 78405.
ITEM 2. IDENTITY AND BACKGROUND.
Paragraph (c) of Item 2 is amended and restated in its entirety as
follows:
(c) Mr. Gallant is the President and Chief Executive Officer of
ADT. His business address is the address of ADT's principal executive
office.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
Item 5 is amended by adding the following information to paragraphs
(a), (b) and (c):
(a) As of the date of Amendment No. 1, Mr. Gallant beneficially
owns 956,864 shares of Stock, constituting 12.8% of the shares of Stock
issued and outstanding. The shares beneficially owned by Mr. Gallant
include 15,000 shares which he has the right to acquire upon exercise of
stock options granted to him as an officer of ADT which are exercisable
currently or within the next 60 days.
(b) Mr. Gallant has sole voting and dispositive power over the
941,864 shares of Stock he currently owns and, upon exercise, will have sole
voting and dispositive power over the 15,000 shares which he has the right
to acquire pursuant to an employee stock option. The shares reflected as
beneficially owned do not include options to purchase a total of 60,000
shares upon exercise of employee stock options which will not become
exercisable until June 20, 2002 and options to purchase a total of 37,500
shares upon exercise of employee stock options which will not become
exercisable unless a change in control of ADT occurs on or before June 22,
2000.
(c) The following transactions in the Stock have occurred since
the filing of the Original Statement:
(i) On June 20, 1997, Mr. Gallant received employee stock
options to purchase a total of 75,000 shares of Stock under ADT's Long-Term
Incentive Plan. All of the options expire ten years after the grant date
and have an exercise price of $5.4375 per share. Options to purchase 15,000
shares became exercisable immediately, while the remaining 60,000 options
become exercisable on June 20, 2002 unless certain performance conditions
were met. Such conditions were not met.
(ii) On July 31, 1999, warrants received by Mr. Gallant to
purchase a total of 477,864 shares (on a split-adjusted basis) expired in
accordance with their terms.
(iii) On December 20, 1999, Mr. Gallant received employee
stock options to purchase a total of 37,500 shares of Stock under ADT's
Long-Term Incentive Plan. All of the options expire June 22, 2000 and have
an exercise price of $3.50 per share. None of the options are exercisable
unless a change in control of ADT occurs.
SIGNATURE
After reasonable inquiry and to the best of his knowledge and
belief, the undersigned certifies that the information set forth in this
amendment is true, complete and correct.
Dated: April __, 2000
/s/ Ben J. Gallant
Ben J. Gallant
